ENVALITH
株式会社ウェルディッシュ logo

Wel-Dish.Incorporated

2901・Standard Market・Foods

Official website
株式会社ウェルディッシュ logo
Wel-Dish.Incorporated2901

Business

Welldish Co., Ltd. traces its roots to a food manufacturer founded in 1957, and changed to its current company name in 2024. It currently operates two core segments: the Wellness Business (sales of food products such as barley tea, health teas, and beef jerky, food services for medical and nursing care institutions, and a home water delivery business) and the Medical Cosmetics Business (OEM manufacturing, wholesale, and direct-to-consumer sales of medical cosmetics). Its main customers span multiple layers, including corporate clients such as medical corporations and social welfare corporations, wholesale partners for China, and general consumers. The company is listed on the Standard Market of the Tokyo Stock Exchange. After 11 consecutive fiscal years of losses, management reforms achieved two consecutive years of profitability, marking the end of its turnaround phase.

Business Model

In the wellness business, the company sells food products manufactured by its Chinese subsidiary (Weihan Ishigaki Foods Co., Ltd.) both domestically and overseas, while also securing stable revenue through corporate contracts to provide food services and bottled water delivery to medical and nursing care institutions. In the medical cosmetics business, the company earns base revenue from OEM supply to competitors and corporate wholesale, while pursuing growth through the store and e-commerce expansion of original products aimed at general consumers. The company employs a strategy of repeatedly incorporating subsidiaries through M&A and executing absorption-type mergers, simultaneously pursuing business synergies and scale expansion.

Company Strengths

Turned profitable within 12 months of management renewal, following 11 consecutive fiscal years of losses. In the transitional 5-month period ended August 2025, the company posted operating profit of ¥32 million and adjusted EBITDA of ¥171 million, achieving profitability for the second consecutive period. Net assets increased to ¥3,271 million through the exercise of convertible bond-type share subscription rights, while liabilities were significantly reduced from ¥1,898 million to ¥554 million.

The consolidation of GRAND ROOF Co., Ltd. as a subsidiary (March 2025) has driven growth in food services and related product sales for medical institutions and welfare/nursing care facilities. In the transitional 5-month period, the Wellness segment posted net sales of ¥1,112 million and operating profit of ¥75 million, with the expanded corporate customer base contributing to sustained profitability.

In the transitional 5-month period, the Medical Cosmetics segment posted net sales of ¥193 million against operating profit of ¥44 million, achieving a segment profit margin of 22.7%. The absorption merger of Medi Art Co., Ltd. has accelerated decision-making and advanced warehouse management DX, laying the foundation for improved production capacity flexibility and further margin improvement.

ENVALITH's Perspective

For the interim period of FY2026 (ending August 2026), operating profit was only ¥5 million (operating margin of 0.3%), and the majority of profit attributable to owners of parent for the interim period, ¥21 million, depends on a gain on debt forgiveness of ¥39 million (extraordinary income). While the company explains that one-off costs such as M&A-related expenses, audit fees, and personnel acquisition costs are pressuring operating profit, achieving the full-year operating profit forecast of ¥310 million would require accumulating over ¥305 million in the remaining six months, and the progress rate (interim ¥5 million against full-year forecast of ¥310 million) is extremely low. Verification of earnings quality and the feasibility of achieving the forecast is essential.

As of the end of February 2026, goodwill balance reached ¥3,971 million (50.7% of total assets), of which ¥1,945 million relating to the acquisition of IMG Holdings is a provisional figure pending finalization of purchase price allocation (PPA). In addition, consolidated subsidiary Mirife has provided debt guarantees totaling ¥12,652 million (reduced to ¥7,254 million as of April 14, 2026) to 14 parties including medical corporations, and the financial impact should these materialize would not be negligible relative to shareholders' equity of ¥5,936 million.

During the interim period, the scope of consolidation changed (two companies added, one excluded), and as a subsequent event, ACA Next became a consolidated subsidiary — multiple M&A transactions were executed within half a year. While the company expects to achieve its medium-term management plan more than a year ahead of schedule, one-off increases in internal control strengthening, audit preparation, and external consulting costs raise the question of whether management systems are keeping pace with the speed of business expansion. As for the external environment, the advancing aging society serves as a tailwind for the medical and elderly-care food service market, but whether integration synergies can be realized will likely be the deciding factor in the stock's valuation.

Growth Strategy

Aiming to achieve the medium-term plan ahead of schedule through concentrated M&A investment in the medical and nursing care sectors and expansion of food services

IMG Holdings was made a wholly owned subsidiary through a share exchange (acquisition cost equivalent to ¥2,382 million) effective December 11, 2025. The aim is to create synergies by combining consulting functions for medical and welfare facilities with the Company's food services. Goodwill of ¥1,945 million (provisional) has arisen, and PPA has not yet been finalized.

On March 2, 2026, shares were acquired for cash consideration of ¥969 million (voting rights ratio of 40.3%), making the company a consolidated subsidiary. This incorporates an extensive sales network to social welfare and medical facilities and a large-scale ready-made meal manufacturing plant, substantially strengthening the manufacturing and distribution foundation for the B2B food services business. Goodwill and the assets/liabilities to be recognized have not yet been finalized.

On February 24, 2026, the food and beverage sales business was spun off through an incorporation-type company split to establish Ishigaki Foods Co., Ltd., with 33% of its issued shares transferred to the second-generation member of the founding family. The aim is to expand B2C sales channels domestically and internationally by leveraging the founding brand, along with clearer KPI management.

System development is scheduled to be completed within 2025, with service launch planned during FY2026 (ending August 2026). The plan is to establish a B2C recurring revenue model by combining ACA Next's ready-made meal manufacturing capabilities with the Company's individual membership base of over 350,000 members.

Capital investment has already been executed in light of a significant increase in wholesale orders bound for China. New sales channels within China are also being developed, and continued sales expansion is expected. Geopolitical risk and changes in Japan-China trade policy are potential downside risk factors.

Last updated: July 17, 2026